Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Services International Inc. was a Canadian medical technology company that specialized in the development and distribution of rapid diagnostic test kits for infectious diseases. The company's primary product line, marketed under the Viro-Check brand, included rapid tests for HIV-1 and HIV-2, as well as diagnostics for Hepatitis B, Hepatitis C, Tuberculosis, and Malaria. These products were designed for ease of use in point-of-care settings, particularly in developing nations where laboratory infrastructure is limited. Although the company was once active on the OTC markets and secured various international distribution agreements, it has since ceased significant operations and is currently considered inactive. The company was headquartered in Edmonton, Alberta, and focused on global health markets. Its diagnostic kits were notable for providing results in minutes without the need for specialized laboratory equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Services International.